Credit rating agency, Credit Analysis and Research (CARE) has reaffirmed ‘A1+’ rating to the various existing short-term bank facilities of Cipla. The company is not availing long-term bank facilities and accordingly the rating for long-term bank facilities has been withdrawn.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.
